Treating Undruggable Cancer Cells
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT06911333
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 11, 2025
Completion: Feb 20, 2030
Loading map...